创新药 (159992.sz)CS创新药 (半年) 银华基金管理股份有限公司持有人户数11.86万 | 成立日期 | 2020-03-20 | 场内资产规模 | 102.26亿元 (2024-12-25) | 基金类型指数型基金(ETF)最新价格0.7110元当前净值0.7117元基金经理马君 、 王帅管理费用率0.50%管托费用率0.05%持仓换手率87.11% (2024-06-30) 成立以来分红再投入年化收益率-6.89% |
| 相关基金: | 联接基金银华中证创新药产业ETF发起式联接A 、 银华中证创新药产业ETF发起式联接C | ||||
| 备注 (4): | 双击编辑备注 |
创新药(159992) - 历史月度涨跌幅
最后更新于：2024-12-25
| 年 | 基金名称 | 1月 | 2月 | 3月 | 4月 | 5月 | 6月 | 7月 | 8月 | 9月 | 10月 | 11月 | 12月 | 年度涨跌幅 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 创新药 | -22.32% | 13.65% | -4.35% | 0.77% | -5.41% | -7.71% | 4.11% | -3.41% | 22.79% | -5.43% | 3.04% | -3.54% | -13.78% |
| CS创新药 | -22.60% | 13.91% | -4.37% | 0.87% | -5.82% | -8.03% | 3.91% | -3.59% | 23.05% | -5.49% | 3.11% | -4.03% | -15.09% | |
| 2023 | 创新药 | 7.57% | -2.71% | -6.28% | -0.14% | -4.92% | -5.95% | 2.44% | -4.73% | 5.47% | 3.66% | 0.81% | -6.52% | -11.94% |
| CS创新药 | 7.74% | -2.72% | -6.31% | -0.10% | -5.16% | -5.99% | 2.25% | -4.88% | 5.62% | 3.77% | 0.85% | -6.31% | -11.91% | |
| 2022 | 创新药 | -16.71% | 3.22% | 3.43% | -14.80% | -0.39% | 13.54% | -9.19% | -3.18% | -9.83% | 5.85% | 4.66% | -0.68% | -25.26% |
| CS创新药 | -16.93% | 3.32% | 3.53% | -15.03% | -0.53% | 13.49% | -9.47% | -3.22% | -9.93% | 5.95% | 4.80% | -0.56% | -25.74% | |
| 2021 | 创新药 | 1.42% | -1.81% | -1.71% | 13.25% | 1.04% | -1.26% | -7.22% | -7.63% | 4.07% | -4.49% | 2.25% | -6.46% | -9.90% |
| CS创新药 | 1.53% | -1.81% | -1.70% | 13.41% | 0.90% | -1.38% | -7.62% | -7.98% | 4.11% | -4.53% | 2.26% | -6.44% | -10.61% | |
| 2020 | 创新药 | -- | -- | -- | 2.98% | 5.11% | 17.35% | 20.67% | -6.05% | -9.97% | 3.38% | -8.72% | 12.69% | -- |
| CS创新药 | 5.10% | 2.60% | -1.68% | 8.67% | 5.02% | 17.80% | 21.02% | -6.19% | -10.14% | 3.35% | -8.84% | 13.24% | 55.14% | |
| 2019 | 创新药 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| CS创新药 | -- | -- | -- | -0.87% | -7.68% | 4.22% | 2.58% | 8.55% | -2.46% | 6.32% | -2.07% | 3.13% | 11.24% |
